Eli Lilly and Company
The Clinical Project Statistician at Lilly provides statistical expertise within clinical research to support the development of medicines. This role partners with multidisciplinary teams and contributes to study design, analysis planning, and data reporting to inform clinical decision-making and regulatory interactions. The position is based within the biostatistics function supporting clinical programs.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
Eli Lilly and Company didn’t post a salary, so this is our estimate from similar listings.
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Director, Biostatistics - Early Phase
Revolution Medicines
Director, Biostatistics - Late Phase
Revolution Medicines
Associate Director, Biostatistics – Early Phase
Revolution Medicines
Sr Manager Biostatistics
Dexcom
Senior Director, Biostatistics
Kardigan
Senior Director, Biostatistics – Late Phase
Revolution Medicines